Publication | Closed Access

A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: A Southwest Oncology Group study

OncologyPhase Ii TrialGastrointestinal OncologyMedicinePharmacotherapyCancer TreatmentPharmacologyAdvanced Pancreas CancerCancer Research